Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalized COVID-19 patients with hypertension and on treatment with an renin-angiotensin system ...

No significant interactions were seen between ACEi or ARB treatment and age, estimated glomerular filtration rate, albuminuria, or diabetes. HealthDay News — For individuals with advanced chronic ...

Pill removed from blister pack The main outcome of the study was hospital presentation due to serious hypoglycemia. Concomitant use of angiotensin-converting enzyme inhibitors (ACEIs) and insulin ...

—Getting kidney patients to stick with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) presents a real challenge. Here are some tips that may help. When it ...

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...

A new study published in the prestigious journal JAMA Cardiology in May 2020 reports that there is no association between the use of ACEIs/ARBs and testing positive for COVID-19. This supports current ...

Blockade of the renin–angiotensin system has beneficial effects in patients with diabetic nephropathy; however, this treatment can induce aldosterone breakthrough and thus become ineffective. New data ...

ACEIs are routinely recommended for the treatment of hypertension, especially in the presence of left ventricular dysfunction and congestive heart failure. [6–10] ACEIs are also indicated for the ...

Three Biomarkers Accurately Detect Kidney Cancer ACE inhibitors and angiotensin-receptor blockers lower the risk for long-term dialysis, death with advanced kidney disease. Use of ACEIs or ARBs is ...